Supernus Pharmaceuticals, Inc. (SUPN)
41.93
+0.24
(+0.58%)
USD |
NASDAQ |
Sep 11, 14:42
Supernus Pharmaceuticals Gross Profit (TTM) : 629.69M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 629.69M |
| March 31, 2026 | 597.34M |
| December 31, 2025 | 552.85M |
| September 30, 2025 | 518.51M |
| June 30, 2025 | 508.22M |
| March 31, 2025 | 510.61M |
| December 31, 2024 | 503.52M |
| September 30, 2024 | 497.32M |
| June 30, 2024 | 471.72M |
| March 31, 2024 | 435.78M |
| December 31, 2023 | 438.90M |
| September 30, 2023 | 438.86M |
| June 30, 2023 | 456.14M |
| March 31, 2023 | 490.42M |
| December 31, 2022 | 493.92M |
| September 30, 2022 | 500.28M |
| June 30, 2022 | 494.35M |
| March 31, 2022 | 475.97M |
| December 31, 2021 | 472.12M |
| September 30, 2021 | 459.43M |
| June 30, 2021 | 462.60M |
| March 31, 2021 | 468.24M |
| December 31, 2020 | 449.20M |
| September 30, 2020 | 428.89M |
| June 30, 2020 | 399.28M |
| Date | Value |
|---|---|
| March 31, 2020 | 384.63M |
| December 31, 2019 | 376.10M |
| September 30, 2019 | 391.51M |
| June 30, 2019 | 392.98M |
| March 31, 2019 | 388.18M |
| December 31, 2018 | 393.54M |
| September 30, 2018 | 366.08M |
| June 30, 2018 | 341.24M |
| March 31, 2018 | 317.36M |
| December 31, 2017 | 284.83M |
| September 30, 2017 | 259.16M |
| June 30, 2017 | 238.58M |
| March 31, 2017 | 215.49M |
| December 31, 2016 | 203.02M |
| September 30, 2016 | 185.31M |
| June 30, 2016 | 168.26M |
| March 31, 2016 | 153.30M |
| December 31, 2015 | 138.27M |
| September 30, 2015 | 125.89M |
| June 30, 2015 | 140.72M |
| March 31, 2015 | 134.82M |
| December 31, 2014 | 116.29M |
| September 30, 2014 | 97.04M |
| June 30, 2014 | 46.89M |
| March 31, 2014 | 18.99M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Indivior Pharmaceuticals, Inc. | 1.116B |
| Pfizer Inc. | 41.30B |
| Amphastar Pharmaceuticals, Inc. | 332.97M |
| Collegium Pharmaceutical, Inc. | 485.09M |
| Bristol Myers Squibb Co. | 32.78B |